AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 124 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97 | -72.6% | 22,986 | -79.9% | 0.01% | -77.1% |
| Q2 2023 | $354 | +216.1% | 114,251 | +41.9% | 0.04% | +218.2% |
| Q1 2023 | $112 | -67.8% | 80,519 | -54.0% | 0.01% | -74.4% |
| Q4 2022 | $348 | -99.9% | 175,049 | +15.3% | 0.04% | -40.3% |
| Q2 2022 | $483,000 | +7.3% | 151,865 | +40.6% | 0.07% | +20.0% |
| Q1 2022 | $450,000 | +181.2% | 107,974 | +223.3% | 0.06% | +200.0% |
| Q4 2021 | $160,000 | -71.9% | 33,402 | -70.0% | 0.02% | -68.8% |
| Q2 2021 | $569,000 | +240.7% | 111,200 | +347.2% | 0.06% | +128.6% |
| Q1 2021 | $167,000 | -7.7% | 24,867 | -37.1% | 0.03% | -6.7% |
| Q4 2020 | $181,000 | -13.4% | 39,552 | -26.6% | 0.03% | -14.3% |
| Q3 2020 | $209,000 | -12.2% | 53,864 | +7.9% | 0.04% | -73.7% |
| Q2 2020 | $238,000 | -30.4% | 49,901 | -49.2% | 0.13% | +54.7% |
| Q1 2020 | $342,000 | -7.1% | 98,239 | +91.6% | 0.09% | +109.8% |
| Q2 2019 | $368,000 | +56.6% | 51,264 | +195.6% | 0.04% | +51.9% |
| Q4 2018 | $235,000 | – | 17,343 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
| Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
| TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
| Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
| Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
| Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
| Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
| Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
| Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
| EAM Investors, LLC | 230,271 | $971,744 | 0.19% |